ask="9.60"
ask_size="200"
average_daily_volume="300368"
bid="5.14"
bid_size="100"
book_value="2.66"
change="+0.30"
change_from_200_day_moving_average="0.20"
change_from_50_day_moving_average="-0.61"
change_from_52_week_high="-1.81"
change_From_52_week_low="2.26"
change_in_percent="+3.35%"
close="9.26"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.30"
ebitda="-117.58M"
eps_estimate_current_year="-1.80"
eps_estimate_next_quarter="-0.67"
eps_estimate_next_year="-2.52"
ex_dividend_date="N/A"
float_shares="14471000"
high="9.32"
high_52_weeks="11.07"
last_trade_date="3/9/2017"
last_trade_price="9.26"
last_trade_size="8008"
last_trade_time="4:00pm"
low="8.96"
low_52_weeks="7.00"
market_capitalization="169.46M"
moving_average_200_day="9.06"
moving_average_50_day="9.87"
name="Akebia Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.00"
open="9.02"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+2.24%"
percent_change_from_50_day_moving_average="-6.19%"
percent_change_from_52_week_high="-16.35%"
percent_change_from_52_week_low="+32.29%"
previous_close="8.96"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.37"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18300000"
short_ratio="8.67"
stock_exchange="NGM"
symbol="AKBA"
volume="301001"
weeks_range_52="7.00 - 11.07"
